Drug details

Andexxa (coagulation factor xa (recombinant), inactivated-zhzo for injection)

type of Factor Xa Inhibitor Antidotes

Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modified human Factor Xa (FXa) protein indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• fever,
• shortness of breath,
• chills,
• chest pain,
• pain spreading to your jaw or shoulder,
• chest pain or pressure,
• sweating
• sudden numbness or weakness,
• pain or burning when you urinate,
• cough with mucus,
• problems with vision or speech,
• continued bleeding after treatment,
• swelling or redness in an arm or leg,
• nausea, and